Investor Relations

Zenabis Presentation

Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations Investor Relations

Zenabis Presentation

Download Presentation

Zenabis Management Discussion and Analysis

Download Presentation

Zenabis Financial Statements

Download Presentation

Zenabis Annual Information Form

Download Presentation

Zenabis Management Discussion and Analysis

Download Presentation

Zenabis Financial Statements

Download Presentation

Zenabis Financial Statements

Download Presentation

Zenabis Management Discussion and Analysis

Download Presentation

Zenabis Management Discussion and Analysis

Download Presentation

Zenabis Financial Statements

Download Presentation

Zenabis Management Circular

Download Presentation
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Press Releases

Zenabis Announces Extension and Partial Conversion of Secured Convertible Notes

Thursday June 4, 2020
Zenabis Announces Extension and Partial Conversion of Secured Convertible Notes Vancouver, British Columbia – June 4, 2020 – Zenabis Global Inc. (TSX:ZENA)…
Read More

ZENABIS PROVIDES UPDATE ON ANNUAL MEETING OF SHAREHOLDERS

Tuesday May 26, 2020
ZENABIS PROVIDES UPDATE ON ANNUAL MEETING OF SHAREHOLDERS VANCOUVER, British Columbia -  May 26, 2020 – Zenabis Global Inc. ("Zenabis" or the…
Read More

Zenabis Obtains EU-GMP Approval to Supply Medical Cannabis to Europe and Amendments to Health Canada License

Wednesday May 20, 2020
Zenabis Obtains EU-GMP Approval to Supply Medical Cannabis to Europe and Amendments to Health Canada License Vancouver, British Columbia – May 20,…
Read More

Zenabis Announces First Quarter 2020 Financial Results

Tuesday May 19, 2020
Zenabis Announces First Quarter 2020 Financial Results Q1 2020 Adjusted EBITDA of $2.3 million compares to an EBITDA loss of $10.4 million…
Read More

Zenabis Provides Corporate Update

Thursday April 30, 2020
Zenabis Provides Corporate Update Vancouver, British Columbia – April 30, 2020 – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today provided…
Read More

Zenabis Announces Amendments to Senior Secured Debenture and Positive Operational Updates

Thursday April 23, 2020
Zenabis Announces Amendments to Senior Secured Debenture and Positive Operational Updates Vancouver, British Columbia – April 23, 2020 – Zenabis Global Inc.…
Read More

IRS Form 8937 (US Investor Tax Information)

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 to report organizational actions, including distributions and reorganizations that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only and should not be construed as legal or tax advice. Zenabis does not provide legal or tax advice. Please consult your personal tax advisor for assistance as to how this information will impact your specific tax situation.

Download Form

Board Policies

The high standards expected of Zenabis Global Inc., officers, and directors are put in place by the Board of Directors and reflect their core values regarding sound corporate governance. Most prominently reflected in them is an understanding of how the fiduciary responsibility the Company has to shareholders receives as much emphasis as the effective and forward-thinking management of company business. The following guidelines details standards and procedures that are in line with this dual-focus approach to operating the company catering to both interests equally. Do note that they may be amended when and as necessary based on the Company's interests or to be in accordance with applicable laws and regulations.

Get the Investor Newsletter

Want to keep in touch? We'll send you our latest updates. You can unsubscribe at any time.

Consent